Company: ABBV
Filing Date: 2025-06-13
Form Type: 11-K
Source: 0001104659-25-059360
Chunk: 2

Company: AbbVie Inc.
Filing Date: 2025-06-13
Form: 11-K
Chunk 2
---
 of
year) as of December 31, 2024 (referred to as the “supplemental schedule”), has been subjected to audit procedures
performed in conjunction with the audit of the Plan’s financial statements. The information in the supplemental schedule is
the responsibility of the Plan’s management. Our audit procedures included determining whether the information reconciles to
the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the
completeness and accuracy of the information presented in the supplemental schedule. In forming our opinion on the information, we
evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor’s
Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the
information is fairly stated, in all material respects, in relation to the financial statements as a whole.

/s/ Ernst & Young LLP

We have served as the Plan’s auditor since 2018.

Chicago, Illinois

June 13, 2025

<div align='center'>4</div>

AbbVie Savings Plan

STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS

December 31, 2024 and 2023

(Dollars in thousands)

| Assets                             |     | 2024 |            |     | 2023 |            |
|:-----------------------------------|:----|:-----|-----------:|:----|:-----|-----------:|
| Investments, at fair value         |     | $    | 13,183,237 |     | $    | 11,550,154 |
| Employer contributions receivable  |     |      |    128,764 |     |      |    108,530 |
| Notes receivable from participants |     |      |     76,683 |     |      |     68,703 |
| Transactions pending investment    |     |      |        229 |     |      |         16 |
| Total assets                       |     |      | 13,388,913 |     |      | 11,727,403 |
| Liabilities                        |     |      |            |     |      |            |
| Accrued investment management fees |     |      |        104 |     |      |        108 |
| Transactions pending redemption    |     |      |        999 |     |      |        127 |
| Total liabilities                  |     |